AbbVie Inc. (ABBV) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    AbbVie Inc.

    NYSE: ABBV · Real-Time Price · USD
    212.53
    -0.47 (-0.22%)
    At close: Sep 05, 2025, 3:59 PM
    212.56
    0.01%
    After-hours: Sep 05, 2025, 04:20 PM EDT

    AbbVie Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 5.52B 12.81B 9.2B 9.75B
    Short-Term Investments
    		 31M 2M 28M 84M
    Long-Term Investments
    		 279M 304M 241M 277M
    Other Long-Term Assets
    		 9.14B 8.51B 5.57B 4.88B
    Receivables
    		 10.92B 11.15B 11.25B 9.98B
    Inventory
    		 4.18B 4.1B 3.58B 3.13B
    Other Current Assets
    		 4.93B 4.93B 4.4B n/a
    Total Current Assets
    		 25.58B 33B 28.46B 27.93B
    Property-Plant & Equipment
    		 5.13B 4.99B 4.93B 5.11B
    Goodwill & Intangibles
    		 95.02B 87.9B 99.59B 108.33B
    Total Long-Term Assets
    		 109.58B 101.71B 110.34B 118.6B
    Total Assets
    		 135.16B 134.71B 138.81B 146.53B
    Account Payables
    		 2.94B 3.69B 2.93B 2.88B
    Deferred Revenue
    		 n/a n/a n/a n/a
    Short-Term Debt
    		 6.8B 7.19B 4.3B 12.67B
    Other Current Liabilities
    		 27.01B 25.16B 20.93B 17.85B
    Total Current Liabilities
    		 38.75B 37.84B 29.54B 35.19B
    Long-Term Debt
    		 60.34B 52.17B 59.12B 64.16B
    Other Long-Term Liabilities
    		 24.38B 24.91B 23.4B 22.02B
    Total Long-Term Liabilities
    		 93.05B 86.47B 91.98B 95.9B
    Total Liabilities
    		 131.8B 124.31B 121.52B 131.09B
    Total Debt
    		 67.84B 60.12B 64.19B 77.58B
    Common Stock
    		 18M 18M 18M 18M
    Retained Earnings
    		 -7.9B -1B 4.78B 3.13B
    Comprehensive Income
    		 -1.93B -2.31B -2.2B -2.9B
    Shareholders Equity
    		 3.33B 10.36B 17.25B 15.41B
    Total Investments
    		 310M 306M 269M 361M

    Add to Watchlist